V Bracho

Summary

Publications

  1. ncbi [Malondialdehyde and nitric oxide behaviour in patients with myocardial infarction]
    V J Bermúdez Pirela
    Catedra de Bioquimica, Escuela de Medicina, Facultad de Medicina Universidad de Zulia, Laboratorio de Investigaciones Endocrinometabólicas Dr Félix Gómez Hospital General del Sur Dr Pedro Iturbe, Maracaibo, Venezuela
    Rev Esp Cardiol 53:502-6. 2000
  2. ncbi Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus
    Valmore J Bermúdez-Pirela
    Endocrine and Metabolic Diseases Research Center Dr Félix Gómez, University of Zulia School of Medicine, Maracaibo, Venezuela
    Am J Ther 14:194-202. 2007
  3. ncbi Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype
    Valmore Bermúdez-Pírela
    Endocrine and Metabolic Diseases Research Center Dr Félix Gómez, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 14:213-20. 2007
  4. ncbi [Lipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (a) levels is transitory]
    V Bermúdez Pírela
    Centro de Investigaciones Endocrino Metabólicas Dr Felix Gómez Facultad de Medicina Universidad del Zulia Maracaibo, Venezuela
    An Med Interna 24:324-7. 2007
  5. ncbi Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:326-33. 2008
  6. ncbi Pharmacologic management of isolated low high-density lipoprotein syndrome
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:377-88. 2008
  7. ncbi Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:409-16. 2008

Collaborators

  • Valmore Bermúdez
  • Nailet Arraiz
  • Freddy Contreras
  • Rafael Hernandez-Hernandez
  • Zafar H Israili
  • Fernando Bermúdez-Arias
  • Valmore J Bermúdez-Pirela
  • Manuel Valasco
  • V Bermúdez Pírela
  • Aida Souki
  • Valmore Bermúdez-Pírela
  • A Amell de Díaz
  • C Cano Ponce
  • V J Bermúdez Pirela
  • Ana Ciscek
  • E Leal Gonzalez
  • Anilsa Amell de Díaz
  • M Lemus Antepaz
  • Clímaco Cano
  • Climaco Cano-Ponce
  • Elliuz Leal-Gonzalez
  • Raquel Cano
  • Guillermo Puche-Medina
  • Miguel Lemus-Antepaz
  • Nilka Leal de Pirela
  • Mayerlim T Medina
  • M Cabrera de Bravo
  • Mayela Cabrera de Bravo
  • E Mengual Moreno
  • Miguel A Lemus
  • Raquel Cano-Peñaloza
  • Hamid A Seyfi
  • Elliuz M Leal
  • Edgardo Mengual-Moreno
  • Nadia Reyna-Villazmil
  • L Sorell Gómez
  • F A Bermúdez Arias
  • M Núñez Pacheco
  • M T Medina Reyes

Detail Information

Publications7

  1. ncbi [Malondialdehyde and nitric oxide behaviour in patients with myocardial infarction]
    V J Bermúdez Pirela
    Catedra de Bioquimica, Escuela de Medicina, Facultad de Medicina Universidad de Zulia, Laboratorio de Investigaciones Endocrinometabólicas Dr Félix Gómez Hospital General del Sur Dr Pedro Iturbe, Maracaibo, Venezuela
    Rev Esp Cardiol 53:502-6. 2000
    ..The aim of this study was to determine the potential usefulness of malondialdehyde and nitric oxide as sensors of metabolic damage produced during acute coronary ischaemics events...
  2. ncbi Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus
    Valmore J Bermúdez-Pirela
    Endocrine and Metabolic Diseases Research Center Dr Félix Gómez, University of Zulia School of Medicine, Maracaibo, Venezuela
    Am J Ther 14:194-202. 2007
    ....
  3. ncbi Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype
    Valmore Bermúdez-Pírela
    Endocrine and Metabolic Diseases Research Center Dr Félix Gómez, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 14:213-20. 2007
    ..Thus, the aim of this study was to determine the effects of ciprofibrate on lipid profile in patients with Frederickson's type IV dyslipidemia phenotype...
  4. ncbi [Lipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (a) levels is transitory]
    V Bermúdez Pírela
    Centro de Investigaciones Endocrino Metabólicas Dr Felix Gómez Facultad de Medicina Universidad del Zulia Maracaibo, Venezuela
    An Med Interna 24:324-7. 2007
    ..Thus, the aim of this study was to determine plasma Lp (a) concentration in a population sample of Maracaibo...
  5. ncbi Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:326-33. 2008
    ..The knowledge of the processes related to these alterations becomes of remarkable importance for understanding the generation of innovative and effective therapeutic strategies for cardiovascular diseases...
  6. ncbi Pharmacologic management of isolated low high-density lipoprotein syndrome
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia, School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:377-88. 2008
    ..In the near future, drugs as beta-glucans, Apo-A1 mimetic peptides, and ACAT inhibitors, are the new promises to treat this condition...
  7. ncbi Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
    Valmore Bermúdez
    Endocrine and Metabolic Diseases Research Center, University of Zulia School of Medicine, Maracaibo, Venezuela
    Am J Ther 15:409-16. 2008
    ..2 +/- 0.4 kg/m, versus insulin-requiring group, 27.1 +/- 0.9 kg/m; P < 0.05). HOMAbetacell determination in clinical practice is a useful tool to determine when insulin therapy should be started for type 2 diabetic patients...